• Maternal IL-17A Deficiency Predicts Neonatal GBS Risk via TL

  2026-07-06

  This study identifies low maternal IL-17A as a prognostic biomarker for invasive Group B Streptococcus (GBS) disease in newborns, linking impaired cytokine response to vertical transmission risk. The findings highlight the value of TLR1/2 pathway stimulation assays for dissecting maternal immunity and inform future biomarker-driven risk stratification.

• PLK1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-07-06

  This study uncovers how Polo-like kinase 1 (PLK1) regulates the function of p31comet in the disassembly of mitotic checkpoint complexes, a process critical for proper chromosome segregation. By identifying a specific phosphorylation event that modulates p31comet activity, the research provides mechanistic clarity relevant for cancer cell cycle investigations and highlights new avenues for targeting mitotic control in cancer research.

• Alosetron as a Precision Tool for 5-HT3 Modulation in GI Ste

  2026-07-05

  Explore how Alosetron, a selective 5-HT3 receptor antagonist, enables advanced gastrointestinal stem cell research through precise modulation of serotonin pathways. This article delivers a unique mechanistic analysis and protocol insights, extending beyond standard application guides.

• Adenosine Triphosphate (ATP) for Advanced Metabolic Pathway

  2026-07-04

  Unlock deeper insights into mitochondrial regulation and metabolic flexibility with high-purity Adenosine Triphosphate (ATP) from APExBIO. This guide delivers actionable protocols, cutting-edge troubleshooting, and real-world applications for ATP-driven cellular metabolism research—integrating the latest findings on TCA cycle regulation and purinergic signaling.

• FCCP: Precision Mitochondrial Uncoupling for Organelle Dynam

  2026-07-03

  Explore the advanced scientific roles of FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) in probing mitochondrial uncoupling and organelle biogenesis. This in-depth analysis connects FCCP's mechanistic potency to emerging insights in peroxisome formation and metabolic regulation.

• Baicalin (SKU N1778): Reliable Pathway Modulation for Transl

  2026-07-03

  This article synthesizes real-world laboratory challenges in neuroplasticity and cancer research, demonstrating how Baicalin (SKU N1778) addresses critical workflow needs for reproducibility and mechanistic clarity. Scenario-driven Q&A blocks offer evidence-based guidance for biomedical scientists, with practical protocol details and vendor comparisons. Explore why APExBIO’s Baicalin is a trusted reagent for KEAP1-NRF2/HO-1 pathway modulation and beyond.

• Tacrolimus (FK506): Dissecting Calcineurin Inhibition in Res

  2026-07-02

  Explore the molecular intricacies of Tacrolimus (FK506) as a calcineurin inhibitor, with a focus on its unique roles in cytokine signaling pathway modulation and immune response suppression. This in-depth analysis connects emerging mechanistic insights to practical research workflows.

• Accurate Quantification of Methylated Purine Nucleosides in

  2026-07-02

  Zhang et al. present a sensitive isotope-diluted UHPLC–MS/MS method enabling precise quantification of ten methylated purine nucleosides, including challenging isomeric forms, in cellular metabolomics. This advancement offers new rigor for profiling RNA modification nucleosides and supports the discovery of purine biomarkers in disease contexts.

• TH287 MTH1 Inhibitor: Mechanisms and Translational Strategie

  2026-07-01

  Explore the mechanistic and strategic frontiers of TH287, a potent MTH1 inhibitor, in radiosensitization and selective cancer cell cytotoxicity. This article synthesizes recent evidence and protocol guidance for translational researchers, positioning TH287 as a precision tool for advancing oxidative stress-induced DNA damage research and targeted cancer therapies.

• PRMT5 Inhibition Reveals Spliceosomal and Metabolic Weakness

  2026-07-01

  This study demonstrates that MYCN-amplified neuroblastoma is acutely vulnerable to PRMT5 inhibition, which disrupts both spliceosomal integrity and glutamine metabolism via epitranscriptomic mechanisms. These findings clarify the mechanistic links between RNA splicing, m6A modification, and metabolic enzyme expression, providing a foundation for precision cancer metabolism research and future therapeutic exploration.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Complex Isol

  2026-06-30

  The Protein A/G Magnetic Co-IP/IP Kit empowers researchers to unravel protein complex interactions with unmatched specificity and reproducibility. Explore workflow optimizations, practical troubleshooting, and insights from cutting-edge BMSC osteogenic differentiation studies that leverage this robust magnetic bead system.

• Palomid 529: Advancing PI3K/Akt/mTOR Targeting in ESCC Resea

  2026-06-30

  Explore the mechanistic role and translational potential of Palomid 529 (P529) in confronting PI3K/Akt/mTOR-driven metastasis and chemoresistance in esophageal squamous cell carcinoma. This article bridges emerging molecular insights—including RCN2-mediated pathway activation—with actionable guidance for translational researchers, setting a new standard for strategic experimental design.

• PEDV Hijacks Host IMPDH Pathway: Evidence for Antiviral Targ

  2026-06-29

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) manipulates host inosine monophosphate dehydrogenase (IMPDH)-dependent guanine nucleotide biosynthesis to facilitate its replication. Genetic and pharmacological inhibition of IMPDH—specifically using Merimepodib (VX-497)—significantly impairs PEDV proliferation, highlighting a host metabolic vulnerability for antiviral intervention.

• LY-411575: Gamma-Secretase Inhibition Beyond Amyloid Beta

  2026-06-29

  Discover how LY-411575, a potent gamma-secretase inhibitor, unlocks new research frontiers in both Alzheimer's disease and cancer immunotherapy. This article uniquely explores the intersection of Notch pathway inhibition and tumor microenvironment modulation, grounded in the latest scientific findings.

• Sumatriptan Succinate: Anti-Inflammatory Potential Beyond Mi

  2026-06-28

  Ala et al. systematically reviewed the anti-inflammatory actions of sumatriptan, a well-known 5-HT1B/1D receptor agonist, highlighting its impact on cytokine modulation and tissue protection in diverse inflammatory models. These findings suggest new applications for sumatriptan succinate in translational inflammation research, expanding its role beyond migraine therapy.

599 records 7/40 page Previous Next First page 上5页 678910 下5页 Last page